Congratulations to the 12 participants whose images have been short listed for the calendar!
This competition was designed to acknowledge and encourage the creativity of our members involved in imaging studies. We had a fantastic turn out and thank all entries for your efforts.
We have short-listed 12 images which will made into a calendar for distribution by The Antibody Society at the Antibody Engineering & Therapeutics meeting in December. Congratulations!
But we would like you, our members and followers, to decide the winner.
The winning image will be featured as the cover image for the 2024 volume of mAbs and the cover image of the calendar. Additionally the member who submitted the winning image will receive broad exposure of their work, a $400 cash prize, and the option of a free registration to:
1) Schrödinger’s online course, Introduction to Computational Antibody Engineering; or
2) virtual or in-person Antibody Engineering & Therapeutics.
2) virtual or in-person Antibody Engineering & Therapeutics.
Click here to vote – polls are open until the 31st of July
The winner will be announced on the 1st of August!
Please see the short listed images below.
-
- Jessica Anania (University of Southampton): Cytoskeletal structures following FcR stimulation
-
- Surrounded: A human iPSC-derived cortical neuron (MAP2 – Cyan Hot) sits happily surrounded by astrocytes (GFAP – Red Hot).
-
- Irene Rosa (University of Florence): Double immunofluorescence staining of human tongue, with DAPI nuclear counterstain
-
- Lorna Stewart (Fusion Antibodies): Expression bottlenecks and antibody localisation in stably transfected CHO cells with a GFP marker.
-
- Isabel Uwagboe (King’s College London): “RAGE” against the machine
-
- Peng Zhao (AstraZeneca): Enhanced anti-angiogenetic effect of transferrin receptor-mediated delivery of VEGF-trap in a glioblastoma mouse model
-
- Gabriel Emilio Herrera-Oropeza (King’s College London): Structure of an Unpatterned Cerebral Organoid
-
- Virginia Metrangolo (University of Copenhagen): Lightening up cancer cells with antibodies
-
- Danielle Fails (Fortis Life Sciences): Immune profiling of axillary lymph tissues
-
- Nathaniel Lam (GSK): Vascularised tumour-on-chip model
-
- Sandra Lara (AstraZeneca): Antibody dependent phagocytosis of 3D tumour spheroids opsonized with Rituximab anti-CD20
-
- Josefa Chuh (Genentech): Preclinical optimization of Ly6E-targeted ADCs for increased durability and efficacy of anti-tumor response
